M

MaineHealth Maine Medical Center | Maine Children's Cancer Program

Research site
(Unclaimed)
Location
100 Campus Drive Suite 107, Scarborough, Maine, United States of America

Site insights

Top conditions

Top treatments

Cyclophosphamide
cyclophosphamide
Vincristine Sulfate
Etoposide
Carboplatin
Doxorubicin Hydrochloride
Vincristine
vincristine sulfate
Methotrexate
Cisplatin

Parent organization

This site is a part of MaineHealth Maine Medical Center

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 120 total trials

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or me...

Enrolling
Locally Advanced Solid Tumors
Primary CNS Tumors
Drug: Oral repotrectinib (TPX-0005)

This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherapy regimen...

Enrolling
Hodgkin Lymphoma
Drug: Etoposide
Drug: DTIC

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harb...

Enrolling
Multiple Myeloma
Advanced Solid Tumors
Drug: Trastuzumab and Pertuzumab
Drug: Palbociclib

Trial sponsors

C
National Cancer Institute (NCI) logo
NYU Langone Health logo
St. Jude Children's Research Hospital logo
Turning Point Therapeutics logo
A
L
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems